Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07476040Not ApplicableNot Yet Recruiting

Improved Management of Patients With Recent-Onset Stable Chest Pain

Role: collaborator

NCT05675319Phase 3Terminated

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Role: collaborator

NCT05818449Not ApplicableActive Not Recruiting

Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)

Role: collaborator

NCT04037501Not ApplicableCompleted

Effectiveness of a Care Management System to Reduce Unmet Needs of Informal Caregivers of People With Dementia

Role: collaborator

All 4 trials loaded